Paull Robert Bradley 4
4 · Kala Pharmaceuticals, Inc. · Filed Jul 21, 2017
Insider Transaction Report
Form 4
Paull Robert Bradley
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-07-19+12,960→ 12,960 totalExercise: $15.00Exp: 2027-07-18→ Common Stock (12,960 underlying)
Footnotes (1)
- [F1]This option was granted, effective on July 19, 2017 and vests over one year, with 8.33% of the shares underlying the option vesting on August 19, 2017, and an addition 8.33% of the shares underlying the option vesting at the end of each successive one-month period thereafter.